GSE161948
Epigenomic profiling of neuroendocrine prostate cancer and prostate adenocarcinoma xenografts
We profiled the epigenomes of neuroendocrine prostate cancer and prostate adenocarcinoma patient-derived xenografts using ChIP-seq for transcription factors and histone modifications. Overall design: ChIP-seq for H3K27ac, H3K4me3, H3K27me3, and FOXA1